Stockscreener 앱 받기
1.99
3.65%
0.07
전일 마감가:
$1.92
열려 있는:
$1.99
하루 거래량:
8,670
Relative Volume:
0.05
시가총액:
$1.95M
수익:
-
순이익/손실:
$-6.85M
주가수익비율:
-0.129
EPS:
-15.4314
순현금흐름:
$-6.23M
1주 성능:
+2.05%
1개월 성능:
-33.22%
6개월 성능:
-66.16%
1년 성능:
-87.66%
1일 변동 폭
$1.91
$2.0205
1주일 범위
$1.70
$2.05
52주 변동 폭
$1.70
$40.80
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
명칭
Bluejay Diagnostics Inc
전화
(978) 631-0152
주소
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
2.004 | 1.87M | 0 | -6.85M | -6.23M | -15.43 |
|
ABT
Abbott Laboratories
|
110.26 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
342.51 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.91 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.96 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.53 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bluejay Diagnostics Inc 주식(BJDX)의 최신 뉴스
Northstrive Fund II has sent a letter to the Board of Directors of Bluejay Diagnostics Inc, recommending that they carefully evaluate a potential acquisition opportunity. - Bitget
NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics - The Manila Times
Braeden Lichti Pushes for Changes at Bluejay Diagnostics with 3.65% Stake - TradingView
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook - marketscreener.com
Aug Opening: Is Bluejay Diagnostics Inc a good ESG investmentMarket Sentiment Report & Technical Pattern Based Buy Signals - baoquankhu1.vn
Bluejay 10-K: Net loss $6.85M, operating loss $6.95M; cash through Q3 2026 - TradingView
Medical diagnostics company Bluejay Diagnostics Inc (stock code: BJDX) is facing financial pressure. According to the company's latest disclosed financial plan, in order to maintain normal operations and advance R&D projects, it must secure at least $20 milli - Bitget
Bluejay Diagnostics says SYMON II study ‘progressing as planned’ - TipRanks
Bluejay’s 20-minute sepsis test drives 2026 plan and $20M cash goal - Stock Titan
BJDX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BJDX Should I Buy - Intellectia AI
ARMISTICE CAPITAL, LLC Acquires Shares in Bluejay Diagnostics Inc - GuruFocus
BJDXBluejay Diagnostics Inc Latest Stock News & Market Updates - Stock Titan
Why is Bluejay Diagnostics Inc. stock going downWeekly Trade Summary & Reliable Momentum Entry Alerts - mfd.ru
Bluejay Diagnostics Completes Warrant Exercises, Clarifies Capital Structure - TipRanks
Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView
Bluejay Diagnostics’ Clinical Study Marks Key Transition from Enrollment to Data Analysis - StocksToTrade
Prefunded warrants fully exercised at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan
Bluejay Diagnostics completes prefunded warrant exercises By Investing.com - Investing.com Canada
Bluejay Diagnostics Announces Full Exercise of Prefunded Warrants and Current Share Structure Update - Quiver Quantitative
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised - marketscreener.com
Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan
Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Advances SYMON II Sepsis Study and Manufacturing - TipRanks
Bluejay Diagnostics enrolls 545 patients in SYMON II study - TipRanks
Bluejay Diagnostics successfully enrolls 545 patients in Symon(TM) II study and advances manufacturing readiness into 2026 - marketscreener.com
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026 - The Manila Times
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON II Study and Advances Manufacturing Readiness into 2026 - Bitget
Bluejay Diagnostics Successfully Enrolls 545 Patients In Symon™ Ii Study And Advances Manufacturing Readiness Into 2026 - TradingView
Bluejay Diagnostics, Inc. Successfully Enrolls 545 Patients in SYMON?? II Study and Advances Manufacturing Readiness into 2026 - marketscreener.com
Is Bluejay Diagnostics Inc. stock a smart retirement pickTrade Exit Summary & Entry Point Confirmation Signals - mfd.ru
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Increase in Short Interest - Defense World
Block Trades: How does Bluejay Diagnostics Inc score in quality rankings2025 Key Highlights & AI Driven Price Predictions - baoquankhu1.vn
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Warrant limits cap Bluejay Diagnostics (NASDAQ: BJDX) at 4.99% - Stock Titan
Bluejay Diagnostics Completes 1-for-4 Reverse Stock Split - TipRanks
Bluejay Diagnostics announces 1-for-4 reverse stock split By Investing.com - Investing.com Australia
Bluejay Diagnostics announces reverse stock split - Medical Buyer
Bluejay Diagnostics announces 1-for-4 reverse stock split - Investing.com
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - marketscreener.com
Bluejay Diagnostics cuts share count to ~708K in 1-for-4 reverse split - stocktitan.net
Valuation Update: Is Bluejay Diagnostics Inc stock a smart retirement pick2025 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Investment Report: How is Bluejay Diagnostics Inc managing supply chain issuesJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Published on: 2026-01-14 07:07:38 - Bộ Nội Vụ
Buybacks Report: Is Bluejay Diagnostics Inc forming a breakout patternTrade Ideas & Community Shared Stock Ideas - baoquankhu1.vn
How Bluejay Diagnostics Inc. stock trades before earnings2025 Major Catalysts & Proven Capital Preservation Methods - ulpravda.ru
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - MSN
Why Bluejay Diagnostics Inc. stock remains a top recommendationJuly 2025 Setups & Technical Pattern Alert System - Улправда
How supply chain issues affect Bluejay Diagnostics Inc. stockSell Signal & Entry Point Confirmation Alerts - ulpravda.ru
Is Bluejay Diagnostics Inc. stock attractive for passive investorsQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Bluejay Diagnostics Inc. stock a safe haven assetJuly 2025 Action & AI Optimized Trade Strategies - Улправда
Bluejay Diagnostics Inc (BJDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.78%
1.06%
자본화:
|
볼륨(24시간):